Uncategorized
Real-world study: CyPass with phaco reduces IOP, medications
LOS ANGELES — Both number of medications and IOP remained reduced at 3 years in a European study of the Alcon CyPass micro-stent combined with cataract surgery, according to a speaker giving results of the CyCLE study.The CyCLE was a registry study in the European Union designed to evaluate the long-term safety and surgical outcomes of the CyPass micro-stent in real-world clinical practice followed for 3 years.